1. Home
  2. NHP vs MNKD Comparison

NHP vs MNKD Comparison

Compare NHP & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Healthcare Properties Inc. Class A Common Stock

NHP

National Healthcare Properties Inc. Class A Common Stock

N/A

Current Price

$16.41

Market Cap

1.1B

Sector

N/A

ML Signal

N/A

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$3.83

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NHP
MNKD
Founded
N/A
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2012
2004

Fundamental Metrics

Financial Performance
Metric
NHP
MNKD
Price
$16.41
$3.83
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$8.69
AVG Volume (30 Days)
543.9K
4.8M
Earning Date
N/A
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
65.09
N/A
EPS
N/A
N/A
Revenue
$342,279,000.00
$348,966,000.00
Revenue This Year
N/A
$35.81
Revenue Next Year
N/A
$11.89
P/E Ratio
N/A
N/A
Revenue Growth
N/A
22.23
52 Week Low
$13.68
$2.23
52 Week High
$17.46
$6.51

Technical Indicators

Market Signals
Indicator
NHP
MNKD
Relative Strength Index (RSI) 59.65 46.84
Support Level $14.54 $3.78
Resistance Level $17.17 $4.15
Average True Range (ATR) 0.79 0.21
MACD 0.00 -0.03
Stochastic Oscillator 60.99 34.62

Price Performance

Historical Comparison
NHP
MNKD

About NHP National Healthcare Properties Inc. Class A Common Stock

National Healthcare Properties Inc is a publicly registered real estate investment trust. It is focused on acquiring, owning, and managing a diversified portfolio of healthcare real estate assets focused on senior housing operating properties (SHOP) and outpatient medical facilities (OMF) in the United States. The company operates in two reportable business segments: SHOP and OMF. The SHOP segment consists of assisted living communities, memory care communities and independent living communities, which are focused on needs-based assisted living and memory care. The OMF segment consists of physicians' offices and examination rooms, hospitals, pharmacies, hospital ancillary service space and other outpatient services. The majority of revenue is derived from the SHOP segment.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Share on Social Networks: